Adaptive Biotechnologies (ADPT) Tops Q3 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $26.64 --0%
Revenue Growth %: -23.8%
Financial Fact:
Selling, marketing and administrative: 9.3M
Today's EPS Names:
AES, SYRS, ZVOI, More
Revenue Growth %: -23.8%
Financial Fact:
Selling, marketing and administrative: 9.3M
Today's EPS Names:
AES, SYRS, ZVOI, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q3 EPS of ($0.32), $0.06 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $47.8 million versus the consensus estimate of $49.05 million.
GUIDANCE:
Adaptive Biotechnologies sees FY2022 revenue of $185-190 million, versus the consensus of $187.5 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Entergy (ETR) Tops Q3 EPS by 31c ; Offers Guidance
- Regal-Beloit (RBC) Tops Q3 EPS by 21c ; Offers Guidance
- Lear Corp. (LEA) Tops Q3 EPS by 39c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
